Skip to main content
Cellular Oncology logoLink to Cellular Oncology
. 2011 Jul 23;34(3):279–280. doi: 10.1007/s13402-011-0055-3

Erratum to: ACP, volume 33, issues 1, 2, 3–4 and 5–6, 2010

The Editor-in-Chief 1,
PMCID: PMC13014582

The Editors

Erratum to: Cell Oncol. (2011) DOI 10.1007/s13402-011-0028-6, DOI 10.1007/s13402-011-0042-8, DOI 10.1007/s13402-011-0029-5, DOI 10.1007/s13402-011-0031-y, DOI 10.1007/s13402-011-0033-9, DOI 10.1007/s13402-011-0034-8

The following articles are being republished in their entirety without any changes in Cellular Oncology. They were previously published in Analytical Cellular Pathology, Volume 33, 2010.

These articles were submitted to the journal Cellular Oncology, but due to some misunderstanding and a title change during 2010, they were published in Analytical Cellular Pathology and not Cellular Oncology .

In order to address this situation, and with the full agreement of the publishers concerned and of the authors, the articles are being republished in the journal Cellular Oncology as originally intended. The articles republished in Cellular Oncology, Volume 34, 2011, should be considered the correct version of record.

Published in Analytical Cellular Pathology volume 33, 2010 as:

H. Geddert, A. zur Hausen, H.E. Gabbert, M. Sarbia, EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1, Anal Cell Pathol 33(3–4), 143–149 (2010), IOS Press

R.P.M. Brosens, E.J.T.H. Belt, J.C. Haan, T.E. Buffart, B. Carvalho, H. Grabsch, P. Quirke, M.A. Cuesta, A.F. Engel, B. Ylstra, G. A. Meijer, Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients, Anal Cell Pathol 33(2), 95–104 (2010), IOS Press

M.J. Nyhan, S. M. El Mashad, T.R. O’Donovan, S. Ahmad, C. Collins, P. Sweeney, E. Rogers, G.C. O’Sullivan, S.L. McKenna, VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin, Anal Cell Pathol 33(3–4), 121–132 (2010), IOS Press

R. Mazzucchelli, D. Morichetti, A. Santinelli, M. Scarpelli, A.V. Bono, A. Lopez-Beltran, L. Cheng, R. Montironi, Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer, Anal Cell Pathol 33(1), 27–36 (2010), IOS Press

B. Pennarun, J.H. Kleibeuker, T. Oenema, J.H. Stegehuis, E.G. E. de Vries, S. de Jong, Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL, Anal Cell Pathol 33(5–6), 229–244 (2010), IOS Press

B. Klink, B. Schlingelhof, M. Klink, K. Stout-Wieder, S. Patt, E. Schrock, Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification, Anal Cell Pathol 33(1), 37–54 (2010), IOS Press

Reprinted in Cellular Oncology volume 34, issue 3, 2011 as:

H. Geddert, A. zur Hausen, H.E. Gabbert, M. Sarbia, EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1, Cell Oncol. 34(3), 209–214 (2011)

R.P.M. Brosens, E.J.T.H. Belt, J.C. Haan, T.E. Buffart, B. Carvalho, H. Grabsch, P. Quirke, M.A. Cuesta, A.F. Engel, B. Ylstra, G. A. Meijer, Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients, Cell Oncol. 34(3), 215–223 (2011)

M.J. Nyhan, S. M. El Mashad, T.R. O’Donovan, S. Ahmad, C. Collins, P. Sweeney, E. Rogers, G.C. O’Sullivan, S.L. McKenna, VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin, Cell Oncol. 34(3), 225–234 (2011)

R. Mazzucchelli, D. Morichetti, A. Santinelli, M. Scarpelli, A.V. Bono, A. Lopez-Beltran, L. Cheng, R. Montironi, Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer, Cell Oncol. 34(3), 235–243 (2011)

B. Pennarun, J.H. Kleibeuker, T. Oenema, J.H. Stegehuis, E.G. E. de Vries, S. de Jong, Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL, Cell Oncol. 34(3), 245–259 (2011)

B. Klink, B. Schlingelhof, M. Klink, K. Stout-Wieder, S. Patt, E. Schrock, Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification, Cell Oncol. 34(3), 261–275 (2011)

Footnotes

The online version of the original article can be found at 10.1007/s13402-011-0028-6, 10.1007/s13402-011-0042-8, 10.1007/s13402-011-0029-5, 10.1007/s13402-011-0031-y, 10.1007/s13402-011-0033-9, 10.1007/s13402-011-0034-8.


Articles from Cellular Oncology are provided here courtesy of Springer

RESOURCES